NFL Collective Bargaining Agreement
Players’ Rights To Medical Care and Treatment
Section 14(e)Club-Wide Biospecimen Collection
For purposes of this Section “Club- Biospecimen Collection” shall mean any effort to collect, monitor, analyze information on or in connection with the blood, urine or other biospecimen. The provisions of this Section shall not affect a Club physician’s ability to order blood or other biospecimen collection and/or testing of an individual player when he or she determines it is clinically indicated (e.g., to determine if such player is suffering from a medical condition at the player’s request or based on the physician’s clinical judgment). NFL Clubs may not perform Club Biospecimen Collection without the prior written approval of the NFL Players Association. Approved Club Biospecimen Collection is subject to the following limitations:
NFL Clubs intending to conduct a Club Biospecimen Collection must notify the NFL Management Council of their intention to do so, indicating the intended date(s) of the testing and identifying any third parties involved in conducting such testing and forwarding a copy of the player consent form to be used in connection with the testing. The NFL Management Council will forward that information to the NFLPA to ensure compliance with this Section.